1 | Theranostics in Prostate Cancer. | |
Page 1-8 | ||
Zidan, L. | ||
2 | Role of PET/CT in Differentiated Thyroid Carcinoma. | |
Page 9-17 | ||
Maamoun, N.; Moustafa, H. | ||
3 | How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? | |
Page 64-81 | ||
Moustafa, M.; Nagy A.; Gammal, M.; Badawy, A. | ||
4 | Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. | |
Page 39-52 | ||
Deif, D.; Moustafa, H.; Fathy, H.; Abougabal, A.; Elazab, M.; Elahmadawy, M. A. | ||
5 | Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? | |
Page 18-38 | ||
Serry, O.; Moustafa, H.; El-Ghamrawy, K; Tawakol, A. | ||
6 | Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. | |
Page 82-93 | ||
Soli, I. A; Moussa, I.; Ali, D. A.; Kyere, AK; Hasford, F | ||